Gujarat Kidney & Super Speciality, a regional healthcare company, has filed its draft red herring prospectus (DRHP) with the stock market regulator Securities and Exchange Board of India (SEBI) for an IPO.
Gujarat Kidney & Super Speciality IPO is an entirely fresh issue of 2.2 crore equity shares. As it has only a fresh issue, all the IPO proceeds will be used for the companyās purposes.
The company aims to use the IPO for acquiring businesses, buying equipment, and covering its working capital needs.
Gujarat Kidney & Super Speciality IPO Funds DeploymentĀ
The company plans to use ā¹77 crore from the IPO proceeds to acquire Parekhs Hospital in Ahmedabad. Moreover, ā¹12.4 crores will be utilized for partial payment of Ashwini Medical Centre, which has already been bought from them.
Further, ā¹30.2 crore shall go for capital expenditure requirements and ā¹7.3 crore for purchasing robotics equipment for the new hospital in Vadodara.
The ā¹1.5 crore would be used for certain borrowings repayments that have been taken by the company.
Lastly, the rest of the funds would be allocated for the inorganic growth and general purposes.
For Qualified Institutional Buyers, 75% allocation and not more than 15% for NII. Further 10% for retail individuals respectively.
About Gujarat Kidney & Super Speciality Company.Ā
Gujarat Kidney & Super Speciality was founded in 2014 and is known as a regional healthcare company located in Gujarat.
It runs a group of medium-sized hospitals that offer a range of healthcare services, mainly focusing on specialized and advanced treatments.
Gujarat Kidney & Super Specialityās Strategies
- Attract growth through partnerships and acquisitions.Ā
- Always make efforts to enhance current operations.Ā
- Carrying out actions to enhance the efficiency of current operations.
- Continue to recruit and retain skilled healthcare professionals
- Strengthen our existing hospitals and their offerings and add new capabilities and specialties.Ā
Details of Promoters and Managing Directors
The company is led by a promoter and a managing director. Dr Pragnesh Yashwantsingh Bharpoda is the companyās promoter and managing director.
They are skilled and have years of experience in the medical industry, enhancing the companyās growth. Moreover, they have also made a name in the field of urology.
Gujarat Kidney & Super Specialityās Financial Statement
Gujarat Kidney and Super Speciality Limited’s revenue increased in 2024 ā¹41.04 crore, while it was ā¹34.01 crore in 2023. Moreover, profit after tax also grew from ā¹2.80 crore in 2023 to ā¹4.34 crore in 2024.
Gujarat Kidney & Super Speciality IPO Prospectus:
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | To be Updated Soon |
Gujarat Kidney & Super Speciality Company Financial Report
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | Profit After Tax |
| 2022 | ā¹0.79 | ā¹0.65 | ā¹0.10 |
| 2023 | ā¹0.00 | ā¹0.01 | ā¹0.01 |
| 2024 | ā¹5.48 | ā¹3.21 | ā¹1.71 |
| September 2024 | ā¹18.72 | ā¹11.16 | ā¹5.63 |
Gujarat Kidney & Super Speciality IPO Valuation – FY2024
Gujarat Kidney & Super Speciality IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ā¹0.49 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 15.86% |
| Net Asset Value (NAV): | ā¹3.09 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Yatharth Hospital & Trauma Care Services Limited | 14.46 | 28.64 | 13.09 | 101.84 | 670.55 Cr. |
| GPT Healthcare Limited | 5.96 | 23.66 | 21.86 | 26.63 | 400.19 Cr. |
| KMC Speciality Hospitals (India) Ltd | 1.86 | 34.19 | 24 | 8.80 | 177.18 Cr. |
Objects of the Issue
- Proposed acquisition of āParekhs Hospital Private Limitedā at Ahmedabad
- Part payment of purchase consideration for the already acquired hospital i.e. āAshwini Medical Centreā
- Funding of capital expenditure requirements of our Company towards setting up of a new hospital exclusively for womenās health care in Vadodara;
- Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital at Vadodara location
- Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by our Company and
- Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.
IPO Lead Managers aka Merchant Bankers
- Nirbhay Capital Services Private Limited
